SC Filed 2023-10-31 Event — SEC 0001140361-23-050328 →

GNI Group Ltd. → GYRE THERAPEUTICS, INC. GYRE

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (16.3 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

16 13D/G filings on this issuer

15 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 16.30

1,927,774 shares short · +0.5% vs prior

Other 13D/G Filings on GYRE THERAPEUTICS, INC.

Filed	Form	Filer	Stake	Shares
2023-11-01	SC	GNI Group Ltd.	—	—	view →
2022-09-22	SC	JEC II Associates, LLC	—	—	view →
2022-07-01	SC	JEC II Associates, LLC	—	—	view →
2022-05-25	SC	SINGER JULIAN D.	—	—	view →
2022-03-16	SC	SINGER JULIAN D.	—	—	view →
2022-03-07	SC	SINGER JULIAN D.	—	—	view →
2022-02-28	SC	SINGER JULIAN D.	—	—	view →
2022-02-23	SC	SINGER JULIAN D.	—	—	view →
2022-01-27	SC	SINGER JULIAN D.	—	—	view →
2022-01-05	SC	SINGER JULIAN D.	—	—	view →
2021-10-26	SC	SINGER JULIAN D.	—	—	view →
2020-01-17	SC	SINGER JULIAN D.	—	—	view →
2019-12-31	SC	SINGER JULIAN D.	—	—	view →
2018-02-14	SC	Morgenthaler Partners VIII LP	—	—	view →
2018-02-09	SC	HealthCare Ventures VIII, L.P.	—	—	view →

Other Filings by GNI Group Ltd.

Filed	Form	Issuer	Stake	Shares
2023-11-01	SC	GYRE THERAPEUTICS, INC. GYRE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →